!Discover over 1,000 fresh articles every day

Get all the latest

نحن لا نرسل البريد العشوائي! اقرأ سياسة الخصوصية الخاصة بنا لمزيد من المعلومات.

Hope arises that the vaccine can protect people with HIV from a deadly threat.

Tests on monkeys carrying a version of the HIV virus show that the BCG vaccine provides protection against the bacteria that cause tuberculosis.

Tests conducted on monkeys carrying a version of the HIV virus demonstrate that the BCG vaccine, developed in the early 20th century, offers protection against the bacteria that cause tuberculosis. Monkeys infected with the HIV virus can develop immunity to tuberculosis after the BCG vaccine is injected into their bloodstream.

Tuberculosis and the BCG vaccine

Tuberculosis is an infectious disease caused by the bacteria Mycobacterium tuberculosis. This bacteria can be kept at bay using a vaccine developed in the early 20th century. The BCG vaccine is effective in preventing tuberculosis and is widely used in many countries.

Protection from tuberculosis in monkeys infected with HIV

Tests show that monkeys carrying a version of the HIV virus can gain immunity to tuberculosis after the BCG vaccine is injected into their bloodstream. This means that the BCG vaccine may provide protection against tuberculosis in people infected with the HIV virus.

Importance of the research

Tuberculosis poses a serious threat to public health worldwide. However, individuals infected with the HIV virus are at greater risk of contracting tuberculosis and developing advanced forms of the disease. Therefore, the new finding regarding the effectiveness of the BCG vaccine in protecting individuals infected with the HIV virus from tuberculosis enhances hope for controlling this disease and protecting the most vulnerable populations.

Conclusion

Studies indicate that the BCG vaccine may provide protection against tuberculosis in people infected with the HIV virus. This discovery fosters hope for controlling tuberculosis and protecting the most at-risk populations. Further research is needed to determine the effectiveness of the BCG vaccine in preventing tuberculosis in individuals infected with the HIV virus and to improve vaccination strategies for this important patient group.

Source: https://www.nature.com/articles/d41586-023-03220-1

.lwrp .lwrp-list-row-container{
display: flex;
justify-content: space-between;
}
.lwrp .lwrp-list-row-container .lwrp-list-item{
width: calc(12% – 20px);
}
.lwrp .lwrp-list-item:not(.lwrp-no-posts-message-item){

}
.lwrp .lwrp-list-item img{
max-width: 100%;
height: auto;
object-fit: cover;
aspect-ratio: 1 / 1;
}
.lwrp .lwrp-list-item.lwrp-empty-list-item{
background: initial !important;
}
.lwrp .lwrp-list-item .lwrp-list-link .lwrp-list-link-title-text,
.lwrp .lwrp-list-item .lwrp-list-no-posts-message{

}@media screen and (max-width: 480px) {
.lwrp.link-whisper-related-posts{

}
.lwrp .lwrp-title{

}.lwrp .lwrp-description{

}
.lwrp .lwrp-list-multi-container{
flex-direction: column;
}
.lwrp .lwrp-list-multi-container ul.lwrp-list{
margin-top: 0px;
margin-bottom: 0px;
padding-top: 0px;
padding-bottom: 0px;
}
.lwrp .lwrp-list-double,
.lwrp .lwrp-list-triple{
width: 100%;
}
.lwrp .lwrp-list-row-container{
justify-content: initial;
flex-direction: column;
}
.lwrp .lwrp-list-row-container .lwrp-list-item{
width: 100%;
}
.lwrp .lwrp-list-item:not(.lwrp-no-posts-message-item){

}
.lwrp .lwrp-list-item .lwrp-list-link .lwrp-list-link-title-text,
.lwrp .lwrp-list-item .lwrp-list-no-posts-message{

};
}


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *